Physician profile
Parth Patel
NPI 1235583055
$1,215.94
in general payments reported to CMS, 2019-2025
12 companies · $833 in 2025
The $833 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $145 · 2023: $60.12 · 2024: $14.57 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $241.09 | 2025 | |
| Atricure, INC. | $189.22 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $167.76 | 2025 | Inspiris Resilia Aortic Valve, Carpentier-Edwards Physio Annuloplasty Ring With Holder - Mitral |
| Abiomed | $150.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Genentech, INC. | $121.89 | 2022 | |
| Baxter Healthcare | $67.96 | 2021-2025 | Perclot |
| Medtronic, INC. | $60.12 | 2023 | Simulus |
| Elite Orthopedics, LLC | $28.36 | 2025 | |
| Kestra Medical Technology Services, INC. | $26.74 | 2025 | Assure Wcd |
| Mallinckrodt Hospital Products INC. | $23.23 | 2022 | |
| Axsome Therapeutics, INC. | $14.57 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.